[{"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "NIH and ivermectin", "description": "HIH, Table 2e. Characteristics of Antiviral Agents That Are Approved or Under Evaluation for the Treatment of COVID-19\n\nhttps://www.covid19treatmentguidelines.nih.gov/tables/table-2e/\n\nhttps://www.cms.gov/medicare/covid-19/new-covid-19-treatments-add-payment-nctap\n\nFDA live\n\nhttps://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19\n\nNIH live\n\nhttps://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/\n\nAdults: Dosing Regimens\n\nThe dose most commonly used in clinical trials is IVM 0.2\u20130.6 mg/kg PO given as a single dose or as a once-daily dose for up to 5 days.\n\nAdverse events\n\nGenerally well tolerated\n\nDizziness\n\nPruritis\n\nGI effects (e.g., nausea, diarrhea)\n\nNeurological AEs have been reported when IVM has been used to treat parasitic diseases, \n\nbut it is not clear whether these AEs were caused by IVM or the underlying conditions.\n\nComments and links to clinical trials\n\nGenerally given on an empty stomach with water; however, administering IVM with food increases its bioavailability.\n\nA list of clinical trials is available here: Ivermectin\n\nRussia\n\nDeaths, \n\nhttps://coronavirus.jhu.edu/region/russia\n\nhttps://www.washingtonpost.com/world/europe/russia-covid-count-fake-statistics/2021/10/16/b9d47058-277f-11ec-8739-5cb6aba30a30_story.html\n\nIndependent demographer Alexey Raksha\n\nUsing data from Rosstat, Russia\u2019s statistical agency\n\nhttps://eng.rosstat.gov.ru/folder/11335\n\nExcess mortality, around 750,000\n\nhttps://www.themoscowtimes.com/2021/10/08/russias-coronavirus-excess-death-toll-hits-660k-a75254\n\nExcess mortality, around 660,000\n\nTracking cases around the world\n\nOfficials manipulated statistics and underplayed the crisis\n\nChina, Turkey\n\nhttps://www.washingtonpost.com/world/asia_pacific/world-health-organization-china-not-sharing-data-on-health-care-worker-coronavirus-infections/2020/02/26/28064fda-54e4-11ea-80ce-37a8d4266c09_story.html\n\nAlexei Kouprianov, independent analyst and biologist\n\nThe data for [Russia] is absolutely unreliable\n\nRecently ex St. Petersburg campus of the Higher School of Economics (September 2020)\n\nHandling of the pandemic, largely left to the regions\n\nRegional officials conceal problems, fear of losing their posts\n\nTherefore critics, even analytical experts, are sidelined\n\nIceland restricts Moderna\n\nhttps://www.landlaeknir.is/um-embaettid/frettir/frett/item47722/Aframhaldandi-notkun-COVID-19-boluefnis-Moderna-a-Islandi\n\nhttps://www.icelandreview.com/society/covid-19-in-iceland-moderna-vaccine-used-for-60/\n\nhttps://www.icelandreview.com/news/moderna-use-on-pause-in-iceland/\n\nChief Epidemiologist, \u00de\u00f3r\u00f3lfur Gu\u00f0nason\n\nModerna, only be used for booster shots in 60+\n\nUnpublished data from the Nordic countries indicate that the risk of cardiac inflammation after vaccination against COVID-19 is much higher among 18 to 39-year-olds if the Moderna vaccine is used than after vaccination with the Pfizer vaccine\n\nCardiac inflammation after vaccination is much less common among older demographics\n\nIn 12 to 17-year-olds, lack of European data\n\nUnder 60 who have received a single shot of Modern, to complete their vaccination with Pfizer\n\nMen 18-39 are not recommended to accept the Moderna COVID-19 vaccine\nIceland data, vast majority of vaccination side effects emerge shortly after vaccination", "link": "https://www.youtube.com/watch?v=2F-Ml9gHnqA", "date_published": "2021-10-18 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}, {"source": "https://www.youtube.com/feeds/videos.xml?channel_id=UCF9IOB2TExg3QIBupFtBDxg", "title": "Viral origins, last chance saloon", "description": "WHO and viral origins, Link to featured video\nhttps://www.youtube.com/watch?v=E18Jbmz6D1I&t=308s\n\nLink to Wefwafwa\u2019s channel\nhttps://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7ow\n(he needs more suscribers)\n\nLink to Patrion to support Wefwafwa\u2019s work in Africa\npatreon:https://www.patreon.com/awmedicalvideos\n\nhttps://www.reuters.com/business/healthcare-pharmaceuticals/who-says-it-may-be-last-chance-find-covid-origins-2021-10-13/\n\nNewly formed advisory group on dangerous pathogens\n\nMike Ryan\n\nThis is our best chance, and it may be our last chance to understand the origins of this virus\n\ntake a step back, create an environment where we can again look at the scientific issues\n\nUrged China to provide data from early cases\n\nChina, no more visits are needed\n\nPrevious WHO team spent four weeks in and around Wuhan\n\nDr Peter Daszak, recused himself from The Lancet's inquiry commission\n\nhttps://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30418-9/fulltext\n\nWe stand together to strongly condemn conspiracy theories suggesting that COVID-19 does not have a natural origin. \n\nDr. Tedros Adhanom Ghebreyesus\n\nInvestigation was hampered by a dearth of raw data pertaining to the first days of the outbreak\n\nHas called for lab audits\n\nNew, 26 members, Scientific Advisory Group on the Origins of \n\nNovel Pathogens (SAGO)\n\nMaria van Kerkhove, WHO technical lead on COVID-19\n\nHopes there would be further WHO-led international missions to China,\n\nwhich would engage the country's cooperation\n\nmore than three dozen recommended studies required to determine how the virus crossed from the animal species to humans\n\nReported Chinese testing for antibodies in Wuhan residents in 2019 will be absolutely critical\n\nIncluding analyses of stored blood samples from 2019 in Wuhan\n\nand retrospective searches of hospital and mortality data for earlier cases.\n\nChen Xu, China's ambassador to the UN\n\nConclusions of the joint study were quite clear\n\nAs international teams had been sent to China twice already, it \n\nis time to send teams to other places", "link": "https://www.youtube.com/watch?v=zHazL7-EyDA", "date_published": "2021-10-17 00:00:00+00:00", "persistent": false, "user": null, "language": "en-US"}]